» Articles » PMID: 6142984

Analysis of Dose-response Curves and Calculation of Agonist Dissociation Constants Using a Weighted Nonlinear Curve Fitting Program

Overview
Specialties Pharmacology
Toxicology
Date 1983 Dec 1
PMID 6142984
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The KA value of a full agonist (Furchgott, 1966) is usually calculated following the transformation of a rectangular hyperbolic relationship between equiactive concentrations into a linear relationship via a double reciprocal plot. Such a transformation will introduce error into the value of KA unless the pre- and postinactivation dose-response curves are also rectangular hyperbolas. Nonlinear curve fitting computer programs, which have been developed to evaluate radioligand binding data, fit data to rectangular hyperbolas and, thus, can be used to fit concentration-response data for pre- and postinactivation curves. Examination of (-)-isoprenaline concentration-response curves for positive inotropic effects in left atrial preparations from the guinea pig, established before and after treatment with the irreversible antagonist Ro 03-7894, indicated a marked deviation from the theoretical rectangular hyperbola (Hill coefficient greater than 1). This was accounted for by the presence of a threshold effect. The present study reports on the use of the computer program LIGAND to fit a rectangular hyperbola to the pre- and postinactivation curves for an agonist, while simultaneously calculating and allowing for the presence of a threshold phenomenon. Since both curves are fitted to rectangular hyperbolas, the KA values can be calculated with greater precision than that possible from double reciprocal plots constructed from uncorrected concentration-response curves.

Citing Articles

An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. 1985.

Black J, Leff P, Shankley N, Wood J Br J Pharmacol. 2010; 160 Suppl 1:S54-64.

PMID: 20590656 PMC: 2947418. DOI: 10.1111/j.1476-5381.2010.00855.x.


Potencies of antagonists chemically related to iodoproxyfan at histamine H3 receptors in mouse brain cortex and guinea-pig ileum: evidence for H3 receptor heterogeneity?.

Schlicker E, Kathmann M, Bitschnau H, Marr I, Reidemeister S, Stark H Naunyn Schmiedebergs Arch Pharmacol. 1996; 353(5):482-8.

PMID: 8740140 DOI: 10.1007/BF00169166.


Nordimaprit, homodimaprit, clobenpropit and imetit: affinities for H3 binding sites and potencies in a functional H3 receptor model.

Kathmann M, Schlicker E, Detzner M, Timmerman H Naunyn Schmiedebergs Arch Pharmacol. 1993; 348(5):498-503.

PMID: 8114949 DOI: 10.1007/BF00173209.


Novel histamine H3 receptor antagonists: affinities in an H3 receptor binding assay and potencies in two functional H3 receptor models.

Schlicker E, Kathmann M, Reidemeister S, Stark H, Schunack W Br J Pharmacol. 1994; 112(4):1043-8.

PMID: 7952862 PMC: 1910257. DOI: 10.1111/j.1476-5381.1994.tb13188.x.


The 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide facilitates noradrenaline release by blockade of alpha 2-adrenoceptors in the mouse brain cortex.

Schlicker E, Kathmann M, Exner H, Detzner M, Gothert M Naunyn Schmiedebergs Arch Pharmacol. 1994; 349(1):20-4.

PMID: 7908122 DOI: 10.1007/BF00178201.